Evaluation of Therapeutic Agents Targeting the Pathogenesis of Coronary Artery Spasm: A Mini Review

被引：3

作者：

Zhao, Xin ^{[1
]}

Tian, Jinfan ^{[1
]}

Ye, Zhishuai ^{[2
]}

Xu, Mingyue ^{[3
]}

Song, Xiantao ^{[1
]}

Huang, Rongchong ^{[2
]}

机构：

[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiol, Beijing 100029, Peoples R China

[2] Capital Med Univ, Beijing Friendship Hosp, Dept Cardiol, Beijing 100050, Peoples R China

[3] Dalian Med Univ, Affiliated Hosp 1, Dept Cardiol, Dalian 116011, Peoples R China

来源：

CURRENT VASCULAR PHARMACOLOGY | 2021年 / 19卷 / 04期

基金：

中国国家自然科学基金;

关键词：

Coronary artery spasm; endothelial dysfunction; vascular smooth muscle cell hyperreactivity; therapeutic targets; ischemic heart disease; epicardial coronary artery; NITRIC-OXIDE SYNTHASE; LOW-DENSITY-LIPOPROTEIN; STABLE ANGINA-PECTORIS; RHO-KINASE INHIBITOR; VARIANT ANGINA; LONG-TERM; VASOSPASTIC ANGINA; FUNCTIONAL ABNORMALITIES; ENDOTHELIAL DYSFUNCTION; MYOSIN PHOSPHATASE;

D O I：

10.2174/1570161118666200603131119

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Coronary artery spasm (CAS) plays an important role in the pathogenesis of ischemic heart disease. The clinical manifestations of CAS include variant angina, myocardial infarction and sudden death. Although endothelial dysfunction and hyperreactivity of vascular smooth muscle cells have been associated with CAS, the underlying mechanisms remain unclear. Thus, there is a long way to go to truly understand the pathogenesis of CAS to formulate effective treatments. This article discusses the pathophysiological mechanisms as well as downstream molecular pathways of CAS, with a focus on potential therapeutic targets.

引用

页码：347 / 358

页数：12

共 131 条

[51] Supersensitive dilator response to nitroglycerin but not to atrial natriuretic peptide in spastic coronary arteries in coronary spastic angina [J].

Kugiyama, K ;

Ohgushi, M ;

Sugiyama, S ;

Motoyama, T ;

Kawano, H ;

Hirashima, O ;

Yasue, H .

AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (05) :606-610

[52] Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina [J].

Kugiyama, K ;

Motoyama, T ;

Hirashima, O ;

Ohgushi, M ;

Soejima, H ;

Misumi, K ;

Kawano, H ;

Miyao, Y ;

Yoshimura, M ;

Ogawa, H ;

Matsumura, T ;

Sugiyama, S ;

Yasue, H .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (01) :103-109

[53] Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina [J].

Kugiyama, K ;

Yasue, H ;

Okumura, K ;

Ogawa, H ;

Fujimoto, K ;

Nakao, K ;

Yoshimura, M ;

Motoyama, T ;

Inobe, Y ;

Kawano, H .

CIRCULATION, 1996, 94 (03) :266-272

[54] Intractable vasospastic angina [J].

Kurata, C ;

Shimane, A .

HEART, 1997, 78 (01) :93-94

[55] TARGETED MUTATION OF CAV-1 ALLEVIATES THE EFFECT OF ENDOTOXIN IN THE INHIBITION OF ET-1-MEDIATED ENOS ACTIVATION IN THE LIVER [J].

Kwok, Willson ;

Clemens, Mark G. .

SHOCK, 2010, 33 (04) :392-398

[56] Mechanisms of Coronary Artery Spasm [J].

Lanza, Gaetano Antonio ;

Careri, Giulia ;

Crea, Filippo .

CIRCULATION, 2011, 124 (16) :1774-1782

[57] Clinical efficacy of aspirin with identification of intimal morphology by optical coherence tomography in preventing event recurrence in patients with vasospasm-induced acute coronary syndrome [J].

Lee, Yonggu ;

Park, Hwan-Cheol ;

Shin, Jinho .

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2018, 34 (11) :1697-1706

[58] Time to adjust aspirin dose to body weight [J].

Lim, Gregory B. .

NATURE REVIEWS CARDIOLOGY, 2018, 15 (09) :501-501

[59] P-selectin increases angiotensin II-induced cardiac inflammation and fibrosis via platelet activation [J].

Liu, Gaizhen ;

Liang, Bin ;

Song, Xiaosu ;

Bai, Rui ;

Qin, Weiwei ;

Sun, Xu ;

Lu, Yan ;

Bian, Yunfei ;

Xiao, Chuanshi .

MOLECULAR MEDICINE REPORTS, 2016, 13 (06) :5021-5028

[60] Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 [J].

Lozano, Rafael ;

Fullman, Nancy ;

Abate, Degu ;

Abay, Solomon M. ;

Abbafati, Cristiana ;

Abbasi, Nooshin ;

Abbastabar, Hedayat ;

Abd-Allah, Foad ;

Abdela, Jemal ;

Abdelalim, Ahmed ;

Abdel-Rahman, Omar ;

Abdi, Alireza ;

Abdollahpour, Ibrahim ;

Abdulkader, Rizwan Suliankatchi ;

Abebe, Nebiyu Dereje ;

Abebe, Zegeye ;

Abejie, Ayenew Negesse ;

Abera, Semaw P. ;

Abil, Olifan Zewdie ;

Aboyans, Victor ;

Abraha, Haftom Niguse ;

Abrham, Aklilu Rota ;

Abu-Raddad, Laith Jamal ;

Abu-Rmeileh, Niveen Me ;

Abyu, Gebre Y. ;

Accrombessi, Manfred Mario Kokou ;

Acharya, Dilaram ;

Acharya, Pawan ;

Adamu, Abdu A. ;

Adebayo, Oladinieji M. ;

Adedeji, Isaac Akinkumui ;

Adedoyin, Rufus Adesoji ;

Adekanmbi, Victor ;

Adetokunboh, Olatunji ;

Adhena, Beyene Meressa ;

Adhikari, Tara Rattan ;

Adib, Mine G. ;

Adou, Arsene Kouablan ;

Adsuar, Jose C. ;

Afarideh, Mohsen ;

Afshari, Mandi ;

Afshin, Ashkan ;

Agarwal, Gina ;

Aghayan, Sargis Aghasi ;

Agius, Dominic ;

Agrawal, Anurag ;

Agrawal, Sutapa ;

Ahmadi, Alireza ;

Ahmadi, Meltdi ;

Ahmadieh, Flamid .

LANCET, 2018, 392 (10159) :2091-2138

← 1 2 3 4 5 6 7 8 9 10 →